Tonix Pharmaceuticals appoints R. Newcomb Stillwell to Board of Directors

Tonix Pharmaceuticals Holding Corp.

Appointed R. Newcomb Stillwell to Board, effective March 15, 2023.
Stillwell was co-managing partner of Ropes & Gray Boston office with 38 years of corporate law experience.
Board will award stock options with grant date fair value of $42,000, vesting at 2023 Annual Meeting.
No related party transactions or arrangements in connection with appointment.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Newcomb Stillwell

director

TNXP · Tonix Pharmaceuticals Holding Corp.

Effective: 2023-03-15
Filed: February 23, 2023, 6:59 PM ET

appointed Newcomb Stillwell as director of the Company, effective as of March 15, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Newcomb Stillwell was appointed as director at Tonix Pharmaceuticals Holding Corp..

Action: appointed
Role: director

Exact text from the filing

appointed Newcomb Stillwell as director of the Company, effective as of March 15, 2023.

View on SEC.gov

Tonix Pharmaceuticals Holding Corp. filing history →

Source: SEC EDGAR

accession 0001387131-23-002322

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.